Clinical Trial Update: Assess the Efficacy/Safety of Intravitreal Ranibizumab in Patients With Vision Loss Due to Choroidal Neovascularization. [Phase 3]

View source ↗

Summary

Phase 3 trial results and completion update for intravitreal ranibizumab in patients with vision loss due to choroidal neovascularization (CNV). Results were po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Choroidal Neovascularization

Drugs mentioned

• Ranibizumab (ranibizumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Choroidal Neovascularization (CNV) | Phase 3 | Status: COMPLETED | Results posted: 2016-08-26